The Amniotic Products Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of amniotic products has seen significant growth in recent years. The market is projected to increase from $0.99 billion in 2024 to $1.08 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.0%.
The Amniotic Products Global Market Report 2024 predicts that by 2029, the market size for amniotic products will reach $1.52 billion, growing at a compound annual growth rate (CAGR) of 8.9%.
Download Your Free Sample of the 2025 Amniotic Products Market Report and Uncover Key Trends Now!The key drivers in the amniotic products market are:
• Growing patient preference for non-invasive therapies
• Increasing prevalence of chronic wounds
• Increased collaborations and partnerships
• Rising prevalence of ophthalmic disorders
The amniotic products market covered in this report is segmented –
1) By Type: Amniotic Membranes, Amniotic Suspensions
2) By Application: Wound Care, Orthopedics, Ophthalmology, Other Applications
3) By End-Use: Hospitals And Ambulatory Surgical Centers, Other End Users
The key trends in the amniotic products market are:
• Continuous evolution of product technology is a key trend shaping the market's future.
• The strong growth potential of the industry is seen as an emerging trend.
• Regional dynamics are increasingly influencing the future of the market.
• The growth in the target patient population is another trend affecting the market's future.
The major players in the amniotic products market are:
• Stryker Corporation
• Smith & Nephew plc
• Integra LifeSciences Holdings Corporation
• Lucina BioSciences LLC
• Bioventus LLC
• Organogenesis Inc
North America was the largest region in the amniotic products market in 2024